The table below shows ALX ONCOLOGY HOLDINGS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$18.65M
-$24.66M
-$37.92M
-$27.82M
-$20.67M
-$5.13M
Capital expenditure
$50.00K
$60.00K
$148.00K
$690.00K
$589.00K
$7.00K
Investing cash flow
-$105.04M
$27.64M
$26.47M
$42.30M
-$183.92M
-$7.00K
Dividends paid
-
-
-
-
ALXO operating cash flow (10-K history)
ALX ONCOLOGY HOLDINGS INC reported operating cash flow of -$84.14M for fiscal year 2025. That is up 31.0% from -$121.91M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow declined from -$13.19M (FY 2018) to -$84.14M. Figures come from the company's audited annual reports as filed with the SEC.